The project concerns SCA's investments in research, development and innovation related to personal care, tissue and forestry products over the period of 2013-2016.
Objectives
These investments focus on three main areas: i) supporting the development and innovation of new products and services, notably in the hygiene and tissue product segments, targeting at consumer well-being; ii) developing environmentally friendlier and more energy efficient solutions and processes; and iii) improving efficiency and reducing cost of various manufacturing processes.
Comments
Sector(s)
Industry
Proposed EIB finance (Approximate amount)
SEK 1850 million (EUR 219 million)
Total cost (Approximate amount)
SEK 3713 million (EUR 439 million)
Environmental aspects
The project concerns investments in Research and Development that are expected to be carried out in existing facilities, already authorised, and which would therefore not require an EIA under Directive 85/337/EC, amended by Directives 97/11/EC and 2003/35/EC. At appraisal, it will be determined if any of the work to be carried out would require a change to existing environmental permits.
Procurement
The promoter is a private company not operating in the utilities sector, and is thus not covered by EU Directives on procurement.
Status
Under appraisal
-
12/02/2013.
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. Therefore data provided on this page is indicative and cannot be considered to represent official EIB Policy (see also the Explanatory notes).
The EIB is committed to open communication and encourages constructive stakeholder input regarding its activities. Enquiries and comments regarding the EIB’s involvement in a project or the financing facilities, activities, organisation and objectives of the EIB, can be sent to the EIB Infodesk.
Alternatively, EIB can also be contacted through its external offices.
Queries regarding details of a specific project, in particular when EIB loan is under appraisal, should be preferably addressed directly to project promoters.
Any complaint regarding alleged maladministration can be lodged to EIB Complaints Mechanism. The European Ombudsman acts as an independent external accountability mechanism of the EIB.
Zero-tolerance against fraud and corruption
The EIB has a zero-tolerance policy on fraud or corruption. To report allegations of fraud or corruption in EIB-financed projects, please contact the Fraud and Investigation division. All complaints will be treated as strictly confidential, and are handled in line with EIB investigation procedures and the Anti-Fraud Policy.
The EIB is committed to achieving the highest possible level of transparency. The EIB Transparency Policy sets out how EIB discloses information and consults with its stakeholders so as to promote better awareness and understanding of its strategies, policies and operations.
